Pfizer Inc
Close on Oct 30, 2026Market cap $173.95BP/E 40.2Yield 5.64%
Pfizer Restructuring charges recognized in period by Quarter
Restructuring charges recognized in period — Total ($M) ($M)
Pfizer Restructuring charges recognized in period: $419M in Q2 2026, down 666.2% from a year earlier.
Where the Q2 2026 figure comes from
Source: Form 10-Q (filed 2026-08-04) ↗
Reported in Form 10-Q / 10-K Note 3 — Restructuring Charges & Other Costs Associated with Acquisitions and Cost-Reduction/Productivity Initiatives.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Restructuring charges recognized in period — Total ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 28, 2026 | 419 | -666.2% | Form 10-Q (filed 2026-08-04) ↗ |
| Q1 2026 | Mar 29, 2026 | 49 | -92.1% | Form 10-Q (filed 2026-05-05) ↗ |
| Q4 2025 | Dec 31, 2025 | 308 | -53.0% | Form 10-K (filed 2026-02-26) ↗ |
| Q3 2025 | Sep 28, 2025 | 237 | +9.2% | Form 10-Q (filed 2025-11-04) ↗ |
| Q2 2025 | Jun 29, 2025 | -74 | -106.7% | Form 10-Q (filed 2026-08-04) ↗ |
| Q1 2025 | Mar 30, 2025 | 621 | +6,110.0% | Form 10-Q (filed 2026-05-05) ↗ |
| Q4 2024 | Dec 31, 2024 | 656 | -63.6% | Form 10-K (filed 2026-02-26) ↗ |
| Q3 2024 | Sep 29, 2024 | 217 | +205.6% | Form 10-Q (filed 2025-11-04) ↗ |
| Q2 2024 | Jun 30, 2024 | 1,104 | +700.0% | Form 10-Q (filed 2025-08-05) ↗ |
| Q1 2024 | Mar 31, 2024 | 10 | -122.7% | Form 10-Q (filed 2025-05-05) ↗ |
| Q4 2023 | Dec 31, 2023 | 1,803 | +250.8% | Form 10-K (filed 2026-02-26) ↗ |
| Q3 2023 | Oct 1, 2023 | 71 | -59.9% | Form 10-Q (filed 2024-11-04) ↗ |
| Q2 2023 | Jul 2, 2023 | 138 | -6.1% | Form 10-Q (filed 2024-08-05) ↗ |
| Q1 2023 | Apr 2, 2023 | -44 | -202.3% | Form 10-Q (filed 2024-05-08) ↗ |
| Q4 2022 | Dec 31, 2022 | 514 | +504.7% | Form 10-K (filed 2025-02-27) ↗ |
| Q3 2022 | Oct 2, 2022 | 177 | -72.5% | Form 10-Q (filed 2023-11-08) ↗ |
| Q2 2022 | Jul 3, 2022 | 147 | -3,040.0% | Form 10-Q (filed 2023-08-09) ↗ |
| Q1 2022 | Apr 3, 2022 | 43 | +152.9% | Form 10-Q (filed 2023-05-10) ↗ |
| Q4 2021 | Dec 31, 2021 | 85 | -47.2% | Form 10-K (filed 2024-02-22) ↗ |
| Q3 2021 | Oct 3, 2021 | 643 | -12,960.0% | Form 10-Q (filed 2022-11-09) ↗ |
| Q2 2021 | Jul 4, 2021 | -5 | -101.5% | Form 10-Q (filed 2022-08-10) ↗ |
| Q1 2021 | Apr 4, 2021 | 17 | -58.5% | Form 10-Q (filed 2022-05-11) ↗ |
| Q4 2020 | Dec 31, 2020 | 161 | -41.9% | Form 10-K (filed 2023-02-23) ↗ |
| Q3 2020 | Sep 27, 2020 | -5 | -106.0% | Form 10-Q (filed 2021-11-12) ↗ |
| Q2 2020 | Jun 28, 2020 | 338 | -334.7% | Form 10-Q (filed 2021-08-12) ↗ |
| Q1 2020 | Mar 29, 2020 | 41 | +310.0% | Form 10-Q (filed 2021-05-13) ↗ |
| Q4 2019 | Dec 31, 2019 | 277 | -66.5% | Form 10-K (filed 2022-02-24) ↗ |
| Q3 2019 | Sep 29, 2019 | 83 | +8,200.0% | Form 10-Q (filed 2020-11-05) ↗ |
| Q2 2019 | Jun 30, 2019 | -144 | +500.0% | Form 10-Q (filed 2020-08-06) ↗ |
| Q1 2019 | Mar 31, 2019 | 10 | -211.1% | Form 10-Q (filed 2020-05-07) ↗ |
| Q4 2018 | Dec 31, 2018 | 828 | +41,300.0% | Form 10-K (filed 2021-02-25) ↗ |
| Q3 2018 | Sep 30, 2018 | 1 | -98.2% | Form 10-Q (filed 2019-11-07) ↗ |
| Q2 2018 | Jul 1, 2018 | -24 | +4.3% | Form 10-Q (filed 2019-08-08) ↗ |
| Q1 2018 | Apr 1, 2018 | -9 | +80.0% | Form 10-Q (filed 2019-05-09) ↗ |
| Q4 2017 | Dec 31, 2017 | 2 | -99.6% | Form 10-K (filed 2020-02-27) ↗ |
| Q3 2017 | Oct 1, 2017 | 56 | -86.1% | Form 10-Q (filed 2018-11-08) ↗ |
| Q2 2017 | Jul 2, 2017 | -23 | -116.3% | Form 10-Q (filed 2018-08-09) ↗ |
| Q1 2017 | Apr 2, 2017 | -5 | -116.7% | Form 10-Q (filed 2018-05-10) ↗ |
| Q4 2016 | Dec 31, 2016 | 481 | +87.9% | Form 10-K (filed 2019-02-28) ↗ |
| Q3 2016 | Oct 2, 2016 | 404 | -13.9% | SEC Filing ↗ |
| Q2 2016 | Jul 3, 2016 | 141 | +227.9% | SEC Filing ↗ |
| Q1 2016 | Apr 3, 2016 | 30 | -28.6% | SEC Filing ↗ |
| Q4 2015 | Dec 31, 2015 | 256 | – | Form 10-K (filed 2018-02-22) ↗ |
| Q3 2015 | Sep 27, 2015 | 469 | – | SEC Filing ↗ |
| Q2 2015 | Jun 28, 2015 | 43 | – | SEC Filing ↗ |
| Q1 2015 | Mar 29, 2015 | 42 | – | SEC Filing ↗ |
Cite this data
StockData. (2026). Pfizer Restructuring charges recognized in period ($M), quarterly Q1 2015–Q2 2026 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/restruct-chg-tot
See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.